Navigation Links
Abbott Statement on ARBITER 6 - HALTS Results and Abbott's Niaspan (niacin extended-release)
Date:11/15/2009

not statistically significant.

ARBITER 6 - HALTS

The ARBITER 6 - HALTS study explored treatment approaches in patients at high cardiovascular risk already taking statins to control bad LDL cholesterol. The primary endpoint of the study compared the effect on atherosclerosis of raising good HDL cholesterol with the addition of Abbott's Niaspan to a statin versus LDL-lowering with the addition of ezetimibe. There were four secondary endpoints: change in lipid values; a composite endpoint consisting of MACE; drug discontinuation due to adverse effects; and health-related quality of life. ARBITER 6 - HALTS, led by Allen Taylor, M.D., of Washington Hospital Center, was conducted and analyzed independent of Abbott. Abbott provided funding and medication to support the study.

ARBITER 6 - HALTS Study Design and Patient Population

ARBITER 6 - HALTS is a prospective, randomized, parallel group, open-label, blinded endpoint study, which means the treatment was not blinded to patients or the investigators, but the analyses of scans were blinded. The study included 362 patients with coronary heart disease or risk equivalents, LDL less than 100 mg/dL and HDL less than 50 for men or 55 mg/dL for women receiving chronic statin therapy. Baseline mean HDL in the study was 43 mg/dL and mean LDL was 82 mg/dL. At the time of the pre-specified interim analysis, the 208 patients who completed treatment and final imaging were included in the analysis.

NIASPAN Indications

NIASPAN is a prescription medication, used along with diet and exercise, to improve cholesterol levels. NIASPAN raises HDL ("good") cholesterol and lowers LDL ("bad") cholesterol and triglycerides. Niacin is also used to reduce the risk of recurrent heart attacks in patients with high cholesterol. In patients with coronary artery disease and high cholesterol, niacin, in combination with a bile acid binding resin, has b
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
2. Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
3. Abbott Again Honored for Offering One of the Top 10 Leading Workplaces
4. Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
5. Abbott Announces TCT 2009 Activities
6. Abbott Expands Use of Sustainable Packaging as Part of Global Environmental Efforts
7. Abbott Again Named One of the Best Places to Launch a Career by BusinessWeek
8. Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
9. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
10. Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
11. Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... King of Prussia, PA (PRWEB) October 22, 2014 ... Group, is recognized as an industry leader with over ... industry award winning team leader in the areas related ... In addition, Mr. Carlson is an Editorial Advisory Board ... Group Healthcare Council Educator. Blue Fin Group is ...
(Date:10/22/2014)... Steven Reinberg HealthDay Reporter ... quickly add weight and length may be showing a genetic ... In adults, certain genes have been linked to increased body ... in fat and lean muscle, the researchers said. At ... taller. By ages 2 and 3, however, these genes were ...
(Date:10/22/2014)... sisters in high school have developed ways to measure ... use electronic stethoscopes, which electronically amplify body sounds, to ... heartbeats. Ilina, a senior at Port Huron Northern ... to detect early lung damage in people exposed to ... one breath cycle each from 16 smokers, 25 nonsmokers ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... crucial part of conventional in vitro fertilization (IVF) -- the ... take place in a device inside the vagina, new research ... that the device, called an INVOcell, might sharply cut costs ... make the technology more accessible to those who don,t live ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... officials on Monday officially tightened guidelines for health workers treating ... exposure and use of a respirator at all times. ... issue the tougher rules after two Dallas nurses contracted Ebola ... United States, Liberian national Thomas Eric Duncan. Nina Pham is ...
Breaking Medicine News(10 mins):Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
... a Cesarean operation to deliver Japan's male heir. The ... doctor of the Imperial Household agency//. ,he ... the placenta, a condition called as placenta previa. "We ... operation. It is also highly possible that the delivery ...
... places and has put the draft regulation out for consultation//. ... government wanted to know about the people's views ahead of ... that it would be nice if the smoking ban extended ... that the plan would be expensive and is very complicated. ...
... chemicals and pharmaceutical companies have evinced interest to ... Chemicals Co already committing Rs 1,665 crore investment ... , Union Chemicals and Fertilisers Minister Ram Vilas ... led a delegation to Japan recently, said during ...
... human cancers involve mutations in the p53 tumor-suppressor gene, ... protein in defending// against cancer. Similarly, roughly 95 percent ... its DNA-binding core domain, pointing to this region of ... activity. ,Clearly, a detailed view of the ...
... dangers of sun exposure that are backed by research proving ... of developing skin// cancer, Americans are still getting sunburned. ... American Academy of Dermatology reported that 39 percent of respondents ... one sunburn in the previous 12 months, a 22 percent ...
... researchers, in collaboration with investigators at Johns Hopkins University, ... new vaccine against the West Nile virus. ... making its yearly appearance in Middle Tennessee. While no ... the state so far this season, mosquitoes collected from ...
Cached Medicine News:Health News:DNA-bound p53 Tumor Suppressor Protein Structure Determined 2Health News:Age and Socioeconomic Factors Are Strongest Determinants of Sunburn 2Health News:Age and Socioeconomic Factors Are Strongest Determinants of Sunburn 3Health News:University Participating in West Nile Vaccine Trial 2
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... 22, 2014  With a vision to ensure ... a Global Pharmaceutical and Biotech manufacturer selects and ... turnkey solution to protect their animal health brand.  ... Photo - http://photos.prnewswire.com/prnh/20141021/153439 ... and aggregated by the Xyntek and Antares solution ...
(Date:10/22/2014)... DIEGO , Oct. 21, 2014   ... today the latest genomics research centers to purchase ... Salk Institute, the National Cancer Institute (NCI), NIH ... Sequencing Center). Before Irys, obtaining a comprehensive view ... next generation sequencing (NGS) does not deliver the ...
Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Xyntek and Antares Serialization Solution Protects Pets Too! 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
9.5" overall length, 4.5" handle....
15" overall length, 9" handle....
...
EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in ...
Medicine Products: